Cargando…
The First-Reported Case of Drug-Induced Hemolytic Anemia by Piperacillin-Tazobactam in a Premature Neonate: A Case Report and Literature Review
Drugs can have a wide array of effects on hematological cells, including red blood cells (RBCs), white blood cells (WBCs), and platelets. Drug-induced hemolytic anemia (DIHA) can be explained by three different pathophysiological mechanisms. We present a case of a premature neonate born at 34 weeks...
Autores principales: | Salim, Hamza, Musmar, Basel, A Sarhan, Fajr M, Giacaman, Narmeen, Abu Omar, Shatha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10082334/ https://www.ncbi.nlm.nih.gov/pubmed/37038577 http://dx.doi.org/10.7759/cureus.35915 |
Ejemplares similares
-
Piperacillin/tazobactam: Eosinophilic-pneumonia: case report
Publicado: (2021) -
Tazobactam and piperacillin-induced thrombocytopenia: A case report
por: CHEN, HONG, et al.
Publicado: (2016) -
Meropenem/piperacillin/tazobactam: Drug resistance: case report
Publicado: (2021) -
Piperacillin/tazobactam/vancomycin: Cast nephropathy: case report
Publicado: (2022) -
Piperacillin/tazobactam: Acute eosinophilic pneumonia: case report
Publicado: (2021)